These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 10498042)
1. Measures of hypothalamic-pituitary-adrenal function in patients with asthma treated with inhaled glucocorticoids: clinical and research implications. Wolthers OD; Honour JW J Asthma; 1999 Sep; 36(6):477-86. PubMed ID: 10498042 [TBL] [Abstract][Full Text] [Related]
2. Hypothalamic-pituitary-adrenal function in children with asthma and rhinitis treated with topical glucocorticosteroids. Wolthers OD; Honour JW Clin Exp Allergy; 1998 May; 28(5):545-50. PubMed ID: 9645590 [TBL] [Abstract][Full Text] [Related]
3. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma. Sorkness CA; LaForce C; Storms W; Lincourt WR; Edwards L; Rogenes PR Clin Ther; 1999 Feb; 21(2):353-67. PubMed ID: 10211538 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of tests of hypothalamic-pituitary-adrenal axis function used to measure effects of inhaled corticosteroids. Bernstein DI; Allen DB Ann Allergy Asthma Immunol; 2007 Feb; 98(2):118-27. PubMed ID: 17304877 [TBL] [Abstract][Full Text] [Related]
6. Safety of inhaled fluticasone propionate therapy for pediatric asthma - a systematic review. Muley P; Shah M; Muley A Curr Drug Saf; 2013 Jul; 8(3):186-94. PubMed ID: 23859431 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of hypothalamic-pituitary-adrenal axis (HPA) suppression by low-dose (0.5 microg) and standard-dose (250 microg) adrenocorticotropic hormone (ACTH) tests in asthmatic children treated with inhaled corticosteroid (JPEM 2006; 19: 1015-1023). Priftis KN; Papadimitriou A; Anthracopoulos MB; Fretzayas A; Nicolaidou P J Pediatr Endocrinol Metab; 2007 Feb; 20(2):261; author reply 261-2. PubMed ID: 17396445 [No Abstract] [Full Text] [Related]
9. High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society. Boe J; Bakke P; Rødølen T; Skovlund E; Gulsvik A Eur Respir J; 1994 Dec; 7(12):2179-84. PubMed ID: 7713201 [TBL] [Abstract][Full Text] [Related]
10. Safety of the newer inhaled corticosteroids in childhood asthma. Randell TL; Donaghue KC; Ambler GR; Cowell CT; Fitzgerald DA; van Asperen PP Paediatr Drugs; 2003; 5(7):481-504. PubMed ID: 12837120 [TBL] [Abstract][Full Text] [Related]
11. Effects of glucocorticoids on the hypothalamic-pituitary-adrenal axis in children and adults. Gulliver T; Eid N Immunol Allergy Clin North Am; 2005 Aug; 25(3):541-55, vii. PubMed ID: 16054542 [TBL] [Abstract][Full Text] [Related]
12. Headliner in Physiology and Management of Childhood Asthma: Hypothalamic-Pituitary-Adrenal Axis. Akcan N; Bahceciler NN Curr Pediatr Rev; 2020; 16(1):43-52. PubMed ID: 31738144 [TBL] [Abstract][Full Text] [Related]
13. Effects of budesonide inhalation suspension on hypothalamic-pituitary-adrenal-axis function in infants and young children with persistent asthma. Irani AM; Cruz-Rivera M; Fitzpatrick S; Hoag J; Smith JA Ann Allergy Asthma Immunol; 2002 Mar; 88(3):306-12. PubMed ID: 11926625 [TBL] [Abstract][Full Text] [Related]
14. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients. Ringdal N; Lundbäck B; Alton M; Rak S; Eivindson A; Bratten G; Kjaersgaard P Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712 [TBL] [Abstract][Full Text] [Related]
15. Inhaled steroids - too much of a good thing? Wilson JW; Robertson CF Med J Aust; 2002 Sep; 177(6):288-9. PubMed ID: 12225273 [No Abstract] [Full Text] [Related]
16. The hypothalamic-pituitary-adrenal axis in asthmatic children. Priftis KN; Papadimitriou A; Nicolaidou P; Chrousos GP Trends Endocrinol Metab; 2008 Jan; 19(1):32-8. PubMed ID: 18155557 [TBL] [Abstract][Full Text] [Related]
17. [Adrenal effect of inhaled corticosteroids in adult asthmatic patients]. Adachi M; Minoguchi K Nihon Kokyuki Gakkai Zasshi; 2006 Mar; 44(3):151-9. PubMed ID: 16617856 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of hypothalamic-pituitary-adrenal axis suppression by low-dose (0.5 microg) and standard-dose (250 microg) adrenocorticotropic hormone (ACTH) tests in asthmatic children treated with inhaled corticosteroid. Ozbek OY; Turktas I; Bakirtas A; Bideci A J Pediatr Endocrinol Metab; 2006 Aug; 19(8):1015-23. PubMed ID: 16995587 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients. Clark DJ; Lipworth BJ Chest; 1997 Nov; 112(5):1248-52. PubMed ID: 9367464 [TBL] [Abstract][Full Text] [Related]
20. Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis. Li JT; Goldstein MF; Gross GN; Noonan MJ; Weisberg S; Edwards L; Reed KD; Rogenes PR J Allergy Clin Immunol; 1999 Apr; 103(4):622-9. PubMed ID: 10200011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]